BANGALORE: On the final day of the Bangalore India Bio 2012 on Wednesday, experts said the increased international involvement in BT Industry can prompt the government to remove the stringent regulations and make its policies more efficient.
The day also saw a CEO conclave in which some speakers stated that structuring partnerships bears a positive risk to reward ratio and resource allocation as the real challenges.
Rashmi H Barbhaiya,CEO and Managing Director, Advinus Therapeutics Ltd, emphasised that India needs to change its regulation policies if it wants to become a meaningful player in the field.
China is a more viable option over India as its has a transparent regulatory system, he observed.
Speaking at the valedictory programme of the three-day event, M N Vidyashankar, Principal Secretary to the Department of Science and Technology, Information Technology and Bio Technology, Government of Karnataka, said, “The 12th edition of Bangalore India Bio has generated the critical mass to be showcased as the largest and the most business relevant biotech event in this part of the world. The fact that Penn Bio entered into MoUs with the Department of IT, BT and S&T is sufficient testimony to the event being recognised by global players in the field as adding substantial value to every stakeholder.”